A Study of S-740792 in Healthy Adult Study Participants
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
This is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safety, tolerability, and PK of S-740792, in addition, the effect of multiple doses of S-740792 on the PK of midazolam. Part 3 will investigate the relative bioavailability of S-740792 tablet compared to S-740792 suspension and the food effect on the PK of the S-740792 tablet.
Key facts
- Study ID
- NCT06724978
- Run by
- Shionogi
- People needed
- 99
- Starts
- 2024-11-21
- Expected to finish
- 2025-09-24
- Last updated by the study team
- 2025-10-02
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Fortrea Clinical Research Unit, Inc. — Daytona Beach, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.